The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDODS.L Regulatory News (DODS)

  • There is currently no data for DODS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

22 Jan 2020 07:00

RNS Number : 5153A
Dods Group PLC
22 January 2020
 

22 January 2020

Dods Group plc

 ("Dods" or "the Group")

Trading Update

Dods, a leading technology company specialising in data, code, business intelligence and media announces an update on trading for the year ending 31 March 2020.

The Board expects adjusted EBITDA1 for the financial year ending 31 March 2020 to be at least £2.8m2, post implementation of IFRS 16.

As highlighted in the half year report, the uncertain political and economic environment during 2019 and the General Election in December has adversely impacted our publishing, events and training businesses. The continued focus on Brexit and inactivity of new government policy decisions has resulted in a slow start in the fourth quarter and is likely to persist for the remainder of the financial year.

The Dods business intelligence services and Merit operations are performing well and in line with management expectations.

This announcement is released by Dods Group plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), and is disclosed in accordance with the Group's obligations under Article 17 of MAR.

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Group by Nitil Patel, Chief Financial Officer.

 

For further information, please contact: 

 

Dods Group plc

David Hammond - Chairman 020 7593 5500

 

www.dodsgroup.com

 

Liberum (Nomad and Broker)

Neil Patel 020 3100 2000

Cameron Duncan

Louis Davies

 

 1. Adjusted EBITDA is defined as earnings before interest, tax, depreciation, amortisation of intangible assets, share based payments and non-recurring items.

 

2. The impact of implementing IFRS 16 is to increase adjusted EBITDA for the year ended 31 March 2020 by c£1.6 million. The reported £1.4 million adjusted EBITDA for the half year ended 30 September 2019 was after an IFRS 16 adjustment of £0.7 million.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUQWGUPUPPG
Date   Source Headline
9th Jul 20187:00 amRNSDirectorate Change
27th Jun 20187:00 amRNSPosting of Annual Report and Notice of AGM
25th Jun 20187:00 amRNSLaunch of New Products
14th Jun 20187:00 amRNSLaunch of New Products
7th Jun 20187:00 amRNSFinal Results
6th Feb 20182:39 pmRNSIssue of Equity
6th Feb 201810:45 amRNSHolding(s) in Company
29th Nov 20177:00 amRNSDirectorate Changes
16th Nov 20177:01 amRNSHalf-year Report
16th Nov 20177:00 amRNSAcquisition
5th Jul 201710:38 amRNSResult of AGM
12th Jun 20177:00 amRNSNotice of AGM
25th May 20179:14 amRNSAnnual Financial Report
25th May 20177:00 amRNSFinal Results
4th Apr 20178:40 amRNSHolding(s) in Company
20th Feb 20174:08 pmRNSDirector/PDMR Shareholding
16th Feb 201712:45 pmRNSStrategic Investment
5th Jan 20177:00 amRNSNew Corporate Website
24th Nov 20167:00 amRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSDirector/PDMR Shareholding
9th Nov 20167:00 amRNSHalf-year Report
19th Sep 201610:12 amRNSChange of Registered Office
5th Sep 20167:00 amRNSDirectorate Change
4th Aug 20164:42 pmRNSHolding(s) in Company
4th Aug 20167:00 amRNSDirectorate Change
28th Jul 20164:23 pmRNSResult of AGM
4th Jul 201612:00 pmRNSIssue of Equity
31st May 20162:05 pmRNSHolding(s) in Company
26th May 20164:24 pmRNSDirector/PDMR Shareholding
23rd May 20161:12 pmRNSAnnual Financial Report
23rd May 20169:55 amRNSFinal Results
31st Mar 20163:12 pmRNSDirector/PDMR Shareholding
31st Mar 201611:48 amRNSDirector/PDMR Shareholding
29th Mar 20165:31 pmRNSDirector/PDMR Shareholding
29th Mar 201610:40 amRNSIssue of Equity
24th Mar 20165:04 pmRNSDirectorate Change
18th Mar 20167:00 amRNSHolding(s) in Company
27th Oct 201510:13 amRNSHalf Yearly Report
30th Sep 201512:22 pmRNSDirector/PDMR Shareholding
3rd Aug 201511:33 amRNSResult of AGM
21st Jul 20159:38 amRNSHolding(s) in Company
26th Jun 201512:18 pmRNSDirector/PDMR Shareholding
24th Jun 20157:00 amRNSAnnual Financial Report
23rd Jun 20157:00 amRNSPreliminary Results
19th Feb 20156:16 pmRNSDirector/PDMR Shareholding
9th Feb 20155:39 pmRNSDirector/PDMR Shareholding
6th Jan 20152:25 pmRNSDirector/PDMR Shareholding
17th Dec 20144:41 pmRNSDirector/PDMR Shareholding
19th Nov 20143:37 pmRNSDirectorate Change
12th Nov 20147:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.